2024-03-29T05:52:02Z
http://www.ijcto.org/index.php/IJCTO/oai
oai:ojs.ijcto.org:article/61
2014-05-14T17:01:18Z
IJCTO:CASE
Nasal glioma with psammomatous calcification- An unusual presentation
Sherwani, Rana; Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
Akhtar, Kafil; Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
Ray, Prasenjit S; Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
Ahmad, Sayed S; Department of Oral Maxillo-facial Surgery, Sir Ziauddin Dental College, Aligarh Muslim University, Aligarh, India.
Extranasal Glioma; Child; Psammomatous calcification.
Congenital midline swellings of nose are encountered rarely, and nasal gliomas constitute about 5% of such lesions. Various theories have been suggested to explain the pathogenesis. Imaging preferably by MRI is mandated to study the extent and to rule out intracranial extension. Clinically, these masses are firm and incompressible. Histologically, they are made up of astrocytes and neuroglial cells, embedded in fibrous and vascular connective tissue. The mainstay of treatment is conservative surgical excision because nasal gliomas are slow-growing, rarely recurrent, and have no malignant potential. We present a case of congenital extranasal glioma with psammomatous calcification and without any intracranial extension in an eighteen month old boy.--------------------------------------------Cite this article as: Sherwani RK, Akhtar K, Ray PS, Ahmad SS. Nasal glioma with psammomatous calcification- An unusual presentation. Int J Cancer Ther Oncol 2014; 2(2):02027. DOI: 10.14319/ijcto.0202.7
International Journal of Cancer Therapy and Oncology
2014-04-09
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Sherwani
10.14319/ijcto.0202.7
International Journal of Cancer Therapy and Oncology; Vol 2, No 2 (2014): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Sherwani/ijcto.0202.7pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Sherwani/ijcto.0202.7html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/58
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/59
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/60
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/61
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/62
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sherwani/63
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/248
2015-08-15T11:54:27Z
IJCTO:CASE
‘Inverted Y’ field radiotherapy planning with multi-leaf collimator: A single isocentric technique using multiple fields
Sahai, Puja; Department Radiation Oncology, All India Institute of Medical Sciences, New Delhi
Sharma, Seema; Department Radiation Oncology, All India Institute of Medical Sciences, New Delhi
Manigandan, Durai; Department Radiation Oncology, All India Institute of Medical Sciences, New Delhi
Mohanti, Bidhu Kalyan; Department Radiation Oncology, All India Institute of Medical Sciences, New Delhi
Radiation Oncology; Medical Physics
Inverted Y Field; Multi-leaf Collimator; Radiotherapy; Seminoma
The purpose of our study is to describe a planning technique using multi-leaf collimator and asymmetric fields for irradiating an ‘inverted Y’ shaped geometry in a patient with testicular seminoma. The entire target area covering the para-aortic, pelvic, and inguinal nodal regions was split into three fields. Single isocenter half-beam block technique was employed. The fields were planned with antero-posterior and postero-anterior portals with a differential weightage. The dose was prescribed at the respective reference points of the fields. A uniform dose distribution for the entire portal was achieved without any under- or over-dosing at the field junctions.
International Journal of Cancer Therapy and Oncology
2015-04-26
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.32.14
10.14319/ijcto.32.14
International Journal of Cancer Therapy and Oncology; Vol 3, No 2 (2015): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.32.14/ijcto.32.14pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.32.14/274
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.32.14/275
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.32.14/276
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/527
2016-09-18T08:59:14Z
IJCTO:CASE
Adenoid cystic carcinoma of lung: An oncologic rarity treated with definitive chemo-radiation
Purkayastha, Abhishek; Department of Radiation Oncology, Army Hospital Research & Referral, New Delhi
Sharma, Neelam; Department of Radiation Oncology, Army Hospital Research & Referral, New Delhi
Vishwanath, Sundaram; Department of Medical Oncology, Army Hospital Research & Referral, New Delhi
Sunita, B S; Department of Pathology and Molecular Sciences, Army Hospital Research & Referral, New Delhi
Radiation Oncology
Adenoid cystic carcinoma, Lung, Radiotherapy, Chemotherapy
Pulmonary System
Adenoid Cystic Carcinoma is a rare variant of adenocarcinoma originating mainly from salivary glands of the head and neck region distributed throughout the upper aerodigestive tract with a propensity for perineural invasion. Primary adenoid cystic carcinoma of lungs is exceedingly rare accounting for a mere 0.04 to 0.2 percent of all pulmonary neoplasms. The existing scant case reports about this lung malignancy mostly describe small lung lesions managed with upfront surgery followed by adjuvant radiotherapy. We hereby present this case of primary lung parenchymal pathology where the disease was treated with definitive chemo-radiation and to the best of our knowledge; this case is one of the rarest and earliest reports of upfront chemo-radiation in an inoperable primary lung parenchymal ACC. A 43-year-old woman presented with complaints of cough, severe dyspnea, right sided chest pain associated with occasional hemoptysis. Radiographic imaging of thorax showed a large mass lesion with smooth margins measuring 10.2 × 7.3 × 6.8 cm right lower lobe with invasion of adjacent vital structures. Image guided biopsy and immunohistochemical analysis confirmed the diagnosis. She was eventually treated with definitive radiotherapy with concurrent chemotherapy as she was deemed inoperable. Post therapy evaluation by imaging showed a partial response to chemo-radiation, however there was significant symptomatic relief. In view of CD 117 positivity, she has started on oral imatinib mesylate. Presently she is on follow up with a karnofsky performance status of 90%. A thorough review of literature also reveals that our case may be the largest adenoid cystic primary parenchymal pulmonary pathology ever reported.
International Journal of Cancer Therapy and Oncology
None
2016-09-18
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.43.15
10.14319/ijcto.43.15
International Journal of Cancer Therapy and Oncology; Vol 4, No 3 (2016): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.43.15/ijcto.43.15pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.15/533
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.15/626
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/27
2014-03-18T19:33:32Z
IJCTO:CASE
Sebaceous carcinoma of right upper eyelid: case report and literature review
Singh, Shruti; MM Inst. Med sciences & R, Mulana
Kaur, Swarn; BPS Govt Med College for Women, Khanpurkalan, Sonepat
Mohan, Alok; MM Inst Med Sciences & R, Mulana
Goyal, Sunder; Kalpana Chawla Govt Medical College, Karnal
Cancer upper eyelid
Upper eyelid, ocular sebaceous carcinoma, chalazion
skin cancer
Sebaceous gland carcinoma is a rare fast growing cutaneous cancer. It is derived from the adenxal epithelium of sebaceous glands. Sebaceous carcinomas are generally divided into those occurring in periocular or extraocular locations. Ocular sebaceous carcinomas occur most commonly in upper eye lid, in the elderly with a predilection for females and Asian populations. Due to its clinical resemblance with chalazion or other chronic inflammatory conditions, there is a delay in diagnosis. Due to its rarity, we present a case of sebaceous carcinoma of right upper eyelid in a 65-year-old female.----------------------------------------------Cite this article as:Singh S, Kaur S, Mohan A, Goyal S. Sebaceous carcinoma of right upper eyelid: case report and literature review. Int J Cancer Ther Oncol 2013; 1(2):01022.DOI: http://dx.doi.org/10.14319/ijcto.0102.2
International Journal of Cancer Therapy and Oncology
2013-11-14
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Singh
10.14319/ijcto.0102.2
International Journal of Cancer Therapy and Oncology; Vol 1, No 2 (2013): November - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Singh/ijcto.0102.2pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Singh/ijcto.0102.2html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Singh/22
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Singh/23
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Singh/24
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Singh/25
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/217
2015-03-29T11:59:33Z
IJCTO:CASE
Angiomatous nasal polyp: Clinical diagnostic dilemma
Goyal, Sunder; Department of General and Minimal Invasive Surgery, Kalpana Chawla Govt. Medical College, Karnal
Jayvardhan, Ghanshyam; Department of Ear Nose and Throat (ENT), Kalpana Chawla Govt. Medical College, Karnal
Goyal, Snigdha; Department of Pathology, Dr. RML Postgraduate Institute of Medical Sciences, New Delhi
Saini, Isha; Life Line Clinical & Diagnostic Centre, Karnal, Haryana
Medical oncology
Angiomatous Polyp; Bone Destruction; Benign
Nasal polyp
Angiomatous polyp (Angiectatic nasal polyps) is rare and its incidence is 4-5% of all nasal polyps. As it occurs with variable clinical features and there is no confirmatory preoperative investigation, clinical diagnosis can be a dilemma. Clinical picture of angiofibroma, simple antrochoanal polyp and inverted papilloma may resemble with each other. As polyps invade surrounding bone, these should be distinguished from a malignant mass. We present an interesting case of an infarcted angiectatic nasal polyp with extensive surrounding bony destruction. Correct preoperative radiological diagnosis is important to avoid unnecessary extensive surgery. Histopathological evaluation of polyps is mandatory since they require different treatment due to difference in the prognosis.
International Journal of Cancer Therapy and Oncology
NIL
2015-01-10
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0301.8
10.14319/ijcto.0301.8
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0301.8/ijcto.0301.8pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.8/232
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.8/233
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.8/234
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.8/236
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/470
2016-07-13T06:51:30Z
IJCTO:CASE
Bronchial carcinoid with massive ossification: A case report and review of literature
Khalil, Mohamed; Department of Pathology, University of Texas Medical Branch, Galveston, Texas
ELtorky, Mahmoud; Department of Pathology, University of Texas Medical Branch, Galveston, Texas
Surgical Pathology
Bronchial carcinoid, Massive ossification, Bone formation
We report a case of a 47-year-old male with unexplained fatigue, shortness of breath, fever, chronic cough, and weight loss of over 12 pounds over a 3 months period. Chest x-ray revealed complete opacification of the right hemithorax with collapse of the right middle and lower lung lobes and midline shift towards the right. A CT scan with contrast showed a 6 cm mass arising from the right mainstem bronchus that was completely occluding the lumen, causing right lung atelectasis. Histopathologic examination of the tumor revealed an atypical carcinoid tumor with massive ossification. This is a case report and review of the literature of the rare bronchial carcinoid demonstrating bone formation.
International Journal of Cancer Therapy and Oncology
2016-06-19
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.9
10.14319/ijcto.42.9
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.9/ijcto.42.9pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.9/477
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/180
2014-12-13T14:36:25Z
IJCTO:CASE
Unusual bone metastasis from follicular carcinoma thyroid: presenting as a primary bone malignancy
Varshney, Saurabh; Department of E.N.T. & Head Neck Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand
Pant, Harish Chandra; Department of Radiology, Himalayan Institute of Medical Sciences, Dehradun
THYROID CARCINOMA
Follicular Carcinoma; Thyroid; Skeleton Metastasis
METASTASIS, SKELETAL
Osseous metastasis in patients of thyroid carcinoma is not very common, and appendicular skeleton is very rare. Bone metastasis represents a complication, especially of follicular thyroid carcinoma and severely reduces the quality of life causing pain, and fractures. Diagnosis is typically done by correlating clinical suspicion with imaging. Occult clinical presentations usually delay the detection and management of patients with bone metastasis from thyroid carcinoma. There is limited information about the clinical presentations and prognosis of patients with follicular thyroid carcinoma with bone metastasis. We hereby present a case report of right arm swelling diagnosed as metastatic carcinoma having metastasis from thyroid primary.
International Journal of Cancer Therapy and Oncology
NIL
2014-10-02
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/0204.11
10.14319/ijcto.0204.11
International Journal of Cancer Therapy and Oncology; Vol 2, No 4 (2014): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0204.11/ijcto.0204.11pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0204.11/ijcto.0204.11html
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/419
2016-07-16T17:03:00Z
IJCTO:CASE
Ductal carcinoma In-Situ in turner syndrome patient undergoing hormone replacement therapy: A case report
Bawa, Rashmi; Department of Surgery, Pine Health Services, Maine
Matemavi, Praise; Department of Surgery, New York Presbyterian Queens Hospital/Weill Cornell Medical College, New York
Maizlin, Ilan; Department of Surgery, New York Presbyterian Queens Hospital/Weill Cornell Medical College, New York
Sung, Kap-Jae; Department of Surgery, New York Presbyterian Queens Hospital/Weill Cornell Medical College, New York
Surgical Oncology
Turner Syndrome, Ductal Carcinoma In-Situ, DCIS, Hormone Replacement Therapy, HRT, Estrogen Replacement Therapy, Breast Cancer
Breast Cancer
Turner’s syndrome is a rare congenital disease which affects about 1 in every 2500-3000 live-born females. This happens due to chromosomal abnormalities in a phenotypic female, causing increased gonadotropin concentrations and low concentrations of estrogens from infancy. As a result, hormone replacement therapy is started in most adolescent Turner syndrome patients to initiate and sustain sexual maturation. Accordingly, most Turner’s syndrome patients undergo several decades of estrogen replacement therapy, from puberty to post-menopausal age. The highly publicized findings of the Women’s Health Initiative have called into question the appropriateness of hormone replacement therapy in adolescents with Turner’s syndrome. Those concerns were mostly theoretical extrapolations, as few prospective studies of cancer occurrence in women with Turner syndrome have been reported. Consequently, several recent publications have challenged those extrapolations, based on the assertion that the levels of hormone replacement in Turner syndrome patients are well below the physiologic levels observed in normal menstruating women, as well as the fact that these women are significantly younger than those studied by the Women’s Health Initiative. In discord to those reports, we present a case of ductal carcinoma in-situ in a 40-year-old Turner patient, who had undergone over two decades of combined hormone replacement therapy. The patient underwent an elective excisional biopsy for a palpable mass, with histopathology revealing a complex fibroadenoma with a nidus of ductal carcinoma in-situ. The lesion was noted to be estrogen receptor positive and progesterone receptor negative, with heavy staining for HER-2/Neu receptor. The patient was treated with tamoxifen. While a rare case, it is imperative for the astute clinician to keep in mind the consequences of long-term hormone replacement therapy in Turner’s syndrome patients in order to avoid missed diagnosis of breast cancer for optimum management of these patients.
International Journal of Cancer Therapy and Oncology
2016-02-06
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.13
10.14319/ijcto.41.13
International Journal of Cancer Therapy and Oncology; Vol 4, No 1 (2016): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.13/ijcto.41.13pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.13/453
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.13/454
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/91
2014-08-16T18:42:04Z
IJCTO:CASE
Painless pulsatile mass as first presentation of renal cell carcinoma
Hoyland, Kimberley; Department of Urology, Hertfordshire and South Bedfordshire Urological Robotic Cancer Centre, Lister Hospital, UK.
Vasdev, Nikhil; Hertfordshire and South Bedfordshire Urological Robotic Cancer Centre, Lister Hospital, UK.
Nathan, Paul; Department of Oncology, Hertfordshire and South Bedfordshire Urological Robotic Cancer Centre, Lister Hospital, UK.
Hanbury, Damian; Department of Urology, Hertfordshire and South Bedfordshire Urological Robotic Cancer Centre, Lister Hospital, UK.
Renal Cell Carcinoma; Sternal Mass; Outcome
Renal cell carcinoma rarely presents with typical features of abdominal pain, flank mass and haematuria, and up to 30% of patients present with metastases. We present the case of an 81 year old man who presented with a painless, pulsatile sternal metastasis as an initial presentation of renal cell carcinoma. This case highlights the importance of recognizing even unusual presentations of renal cell carcinoma, and that although sternal metastases are rare, when they do occur there should be a low threshold for ruling out renal cell carcinoma.-------------------------------Cite this article as: Hoyland K, Vasdev N, Nathan P, Hanbury D. Painless pulsatile mass as first presentation of renal cell carcinoma. Int J Cancer Ther Oncol 2014; 2(3):02036. DOI: 10.14319/ijcto.0203.6
International Journal of Cancer Therapy and Oncology
2014-05-22
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Hoyland
10.14319/0203.6
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Hoyland/ijcto.0203.6pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Hoyland/ijcto.0203.6html
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/350
2016-01-03T12:17:49Z
IJCTO:CASE
Intestinal pseudo-obstruction: An important diagnostic challenge
Salvador-Coloma, Carmen; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Bennis, Mohamed; Department of Medical Oncology, Hospital de Xativa, Valencia
Díez Langhetée, Lydia; Department of Internal Medicine, Hospital Universitari i Politècnic La Fe, Valencia
Niño Gómez, Óscar; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Reche Santos, Encarnación; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Juan Vidal, Óscar; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Medical Oncology; Internal Medicine
Lung Cancer; Small-Cell Lung Cancer; Anti-HU; Paraneoplastic Syndrome; Intestinal Obstruction
Paraneoplastic syndrome
We present the case of a 72-year-old patient admitted on various occasions with symptoms of intestinal pseudo-obstruction. Extensive diagnostic tests eventually found that the patient had small-cell lung cancer associated with high anti-HU antibody titres, which pointed to a probable paraneoplastic intestinal obstruction syndrome associated with small-cell lung cancer. A paraneoplastic syndrome causing abnormal changes in gastrointestinal motility can be the first signs of small cell lung cancer. These syndromes improve with treatment of the underlying disease, as seen in our patient, who stopped having episodes of intestinal pseudo-obstruction after administration of chemotherapy.
International Journal of Cancer Therapy and Oncology
2015-06-09
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.33.9
10.14319/ijcto.33.9
International Journal of Cancer Therapy and Oncology; Vol 3, No 3 (2015): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.33.9/ijcto.33.9pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.33.9/354
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/597
2017-02-12T15:24:28Z
IJCTO:CASE
Long term survival after brain metastases from malignant melanoma
Salvador-Coloma, Carmen; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Montalar, Joaquín; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Niño, Óscar Mauricio; Department of Medical Oncology, Hospital de Xativa, Valencia
Tormo, Alejandro; Department of Radiation Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Aparicio, Jorge; Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia
Oncology
Malignant melanoma, Brain metastases, Long-term survival, Unresectable brain metastases
We present the case of a 32-year-old patient with malignant melanoma who relapsed with an unresectable brain metastases (BM). He was managed with whole brain radiotherapy (WBRT) and temozolomide chemotherapy. A metabolic positron emission tomography (PET-scan) complete response was achieved. He is living disease-free more than 6 years after the diagnosis of BM. He is now 51 years old and remains asymptomatic and free of disease since then. However, a pronounced residual image still appears on magnetic resonance imaging (MRI) ant PET-scan.
International Journal of Cancer Therapy and Oncology
2016-12-28
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.44.8
10.14319/ijcto.44.8
International Journal of Cancer Therapy and Oncology; Vol 4, No 4 (2016): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.44.8/ijcto.44.8pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.44.8/644
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.44.8/645
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.44.8/646
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/36
2014-04-12T11:23:46Z
IJCTO:CASE
Relapse of unusual localization of classic seminoma with post-chemotherapy transformation
Ureña, Mayte Delgado; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Legerén, Marta; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Gálvez, Fernando; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Villaescusa, Ana; edical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Aparicio, Jorge; Medical Oncology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Jurado, Jose M; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Blancas, Isabel; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Sánchez, Maria; Medical Oncology Service, Hospital Clínico San Cecilio, Granada, Spain.
Romera, Ana L; General Surgery Service, Hospital Clínico San Cecilio, Granada, Spain.
Martínez, Ana P; General Surgery Service, Hospital Clínico San Cecilio, Granada, Spain.
Quiñonez, Enoe; Pathologic Anatomy Service, Hospital Clínico San Cecilio, Granada, Spain.
Dulcey, Isabel; Pathologic Anatomy Service, Hospital Clínico San Cecilio, Granada, Spain.
Puche, Jose L; Pathologic Anatomy Service, Hospital Clínico San Cecilio, Granada, Spain.
Classic Seminoma; Alpha-fetoprotein; Vitelline tumor
Germ cell tumor is the most common cancer among males in the 20–39 year-old age range, representing 21% of invasive cancer diagnose. The vast majority of testicular tumors in this age range are germ cell tumors. There are two types of malignant tumors, the pure seminoma cell and non-seminomatous germinal cell tumors (NGCT). We present the case of a patient who underwent a testicular tumor surgery, classic seminoma stage I, receiving two cycles of adjuvant carboplatin chemotherapy. During the follow up, an elevation on the alpha-fetoprotein level was observed, thus the final diagnosis was adenopatic recurrence of the Yolk Sac tumor.-----------------------------------------------------------------Cite this article as: Urena MD, Legeren M, Galvez F, Villaescusa A, Aparicio J, Jurado JM, Blancas I, Sanchez MJ, Romera AL, Martinez AP, Quiñonez E, Dulcey I, Puche JL. Relapse of unusual localization of classic seminoma with post-chemotherapy transformation. Int J Cancer Ther Oncol 2014; 2(1):02016.DOI: http://dx.doi.org/10.14319/ijcto.0201.6
International Journal of Cancer Therapy and Oncology
2014-01-03
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Urena
10.14319/ijcto.0201.6
International Journal of Cancer Therapy and Oncology; Vol 2, No 1 (2014): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Urena/ijcto.0201.6pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Urena/ijcto.0201.6html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Urena/47
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/243
2015-08-15T11:54:27Z
IJCTO:CASE
Radiotherapy for large cutaneous angiosarcoma of face with RapidArc (VMAT)
Ali, Mirza Athar; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Muntimadugu, Babaiah; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Nagaraju, Madhusudhan; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Vuba, Sujana; Department of Radiation Oncology, American Oncology Institute, Hyderabad
George, Geomcy; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Muralidhar, KR; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Rout, Birendra; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Mariappan, Prabhakar; Department of Radiation Oncology, American Oncology Institute, Hyderabad
Radiation Oncology; Treatment planning; RapidArc (VMAT)
RapidArc; Cutaneous Angiosarcoma
RapidArc for superficial target.
Angiosarcoma is a rare malignancy of vascular origin. It can affect any part of the body, head and neck region being probably the most common site of diagnosis. We present here a case of Angiosarcoma of face in a 67-year-old elderly gentleman who was treated with RapidArc – volumetric modulated arc therapy (VMAT) for recurrence after surgery, radiotherapy and chemotherapy. As an alternative to Electron Beam Therapy, RapidArc with skin bolus can be considered for large complex shaped targets with irregular surface and tissue inhomogeneity. RapidArc plan can achieve adequate target coverage with acceptable dose homogeneity and conformity.
International Journal of Cancer Therapy and Oncology
2015-02-06
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.3
10.14319/ijcto.0302.3
International Journal of Cancer Therapy and Oncology; Vol 3, No 2 (2015): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.3/ijcto.0302.3pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/513
2016-07-13T06:51:30Z
IJCTO:CASE
A case report of long term bevacizumab treatment in multiresistant ovarian cancer
Kargo, Anette; Department of Oncology, Hospital Lillebaelt, Vejle
Adimi, Parvin; Department of Oncology, Hospital Lillebaelt, Vejle
Steffensen, Karina Dahl; Department of Oncology, Hospital Lillebaelt, Vejle
Medical Oncology
Ovarian cancer, Bevacizumab
Treatment of multiresistant ovarian cancer is palliative and patients have needs for less toxic treatment. Anti-angiogenic treatments have a less toxic profile, and bevacizumab has shown improvement of progression free survival (PFS) in front-line trials. Bevacizumab is generally introduced in combination with chemotherapy; however this case report will describe the use of single-agent bevacizumab for more than five years (102 cycles) in a patient with relapse of advanced ovarian cancer.
International Journal of Cancer Therapy and Oncology
2016-06-19
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.14
10.14319/ijcto.42.14
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.14/ijcto.42.14pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.14/522
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/160
2014-12-13T14:36:25Z
IJCTO:CASE
Nasopharyngeal Synovial Sarcoma - An Oncological Surprise
Kannan, Ram Abhinav; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Koushik, Kirthi; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Kilara, Nalini; Department of Medical Oncology, M S Ramaiah Medical College, Bangalore
Gangoli, Aparna; Department of Pathology, HCG Oncology, Bangalore
Head and Neck Oncology
Synovial Sarcoma; Nasopharynx; Surgery; Radiation; Neoadjuvant Chemotherapy
Nasopharyngeal Carcinoma
Synovial sarcoma is a rare and aggressive high-grade neoplasm with poor prognosis. It is usually encountered in the lower extremities of young adults; only a few cases have been reported in the head and neck region. We report the fourth case of synovial sarcoma of the nasopharynx, treated with neoadjuvant chemotherapy, complete surgical excision and adjuvant radiation with extensive review of literature.
International Journal of Cancer Therapy and Oncology
2014-10-09
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/0204.12
10.14319/ijcto.0204.12
International Journal of Cancer Therapy and Oncology; Vol 2, No 4 (2014): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0204.12/ijcto.0204.12pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0204.12/ijcto.0204.12html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.12/184
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.12/185
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.12/186
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.12/188
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.12/189
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/478
2016-07-16T06:37:56Z
IJCTO:CASE
Multifocal, recurrent malignant chondroid syringoma with visceral metastases: A case report and literature review
Garcia, Ann Meredith; Section of Medical Oncology, Department of Medicine, University of the Philippines – Philippine General
Hospital, Manila
Atun, Jenny Maureen; Department of Pathology and Laboratories, University of the Philippines – Philippine General Hospital, Manila
Fernando, Gracieux; Section of Medical Oncology, Department of Medicine, University of the Philippines – Philippine General
Hospital, Manila
Medical Oncology
Malignant Chondroid Syringoma, Malignant Mixed Tumor, Sweat Gland Carcinoma, Eccrine Carcinoma, Adnexal Carcinoma
Skin Cancer
We present the unusual case of malignant chondroid syringoma (MCS) in a 64-year-old male with recurrent nodular skin lesions and visceral metastases. The patient underwent repeated excisions, with eventual development of widespread nodules and multiple pulmonary and hepatic nodules. Systemic chemotherapy was planned. MCS is a very rare skin adnexal tumor of the sweat glands with only around 50 cases reported worldwide. To the authors’ knowledge, this is the first reported case of MCS with a multifocal presentation and mucosal involvement.
International Journal of Cancer Therapy and Oncology
2016-02-15
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.19
10.14319/ijcto.41.19
International Journal of Cancer Therapy and Oncology; Vol 4, No 1 (2016): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.19/ijcto.41.19pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/144
2014-08-16T18:42:04Z
IJCTO:CASE
Coexistent squamous cell carcinoma and tuberculosis in the cervix: a rare case report
Sharma, Mousumi; Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati
Ahmed, Siraj; Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati
Kataki, Amal Chandara; Department of Gynaecologic Oncology, Dr. B. Borooah Cancer Institute, Guwahati
Sarma, Anupam; Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati
Pathology and Oncology
Tuberculosis; Malignancy; Cervix
Pathology and Gynaecology
Tuberculosis may coexist with malignancy. But coexistence of tuberculosis and cancer in cervix is extremely rare. We present a rare case of coexistent squamous cell carcinona and tuberculosis of uterine cervix in a 35 years old lady who presented with chief complaints of white discharge and bleeding per vagina since 1 year. Histopathological findings of carcinomatous nests along with epithelioid granuloma, langhans type of giant cells and positive acid fast bacilli in the tissue section give authenticity to our diagnosis. Tuberculosis complicating malignancy may occur in regions with high prevalence of this disease. Hence, proper diagnosis of tuberculosis in a patient with cancer assumes importance as it may add to the surveillance of the patient........................................................Cite this article as:Sharma M, Ahmed S, Sharma J, Kataki AC, Sarma A. Coexistent squamous cell carcinoma and tuberculosis in the cervix: a rare case report. Int J Cancer Ther Oncol 2014; 2(3):020314. DOI: 10.14319/ijcto.0203.14
International Journal of Cancer Therapy and Oncology
None
2014-07-10
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Sharma
10.14319/ijcto.0203.14
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Sharma/ijcto.0203.14pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Sharma/ijcto.0203.14html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Sharma/170
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/341
2016-01-03T12:17:49Z
IJCTO:CASE
Solitary pulmonary metastasis of pancreatic cancer presenting a thin-walled cavity
Matsuoka, Katsunari; Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Himeji
Ueda, Mitsuhiro; Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Himeji
Miyamoto, Yoshihiro; Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Himeji
thoracic surgery, thoracic oncology
Pancreatic Cancer; Pulmonary; Metastasis; Cavity; Solitary
Because the prognosis of the patients with pancreatic cancer is very poor, there are few opportunities to perform surgery for pulmonary metastasis. Here we report the resection of a solitary pulmonary metastasis from pancreatic cancer, appearing as thin-walled cavity, which appeared 5 years after pancreaticoduodenectomy. Although the present patient underwent incomplete resection because of malignant pleural effusion and pleural dissemination, he is currently still alive without evident recurrence at 18 months after surgery.
International Journal of Cancer Therapy and Oncology
none
2015-06-10
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.33.8
10.14319/ijcto.33.8
International Journal of Cancer Therapy and Oncology; Vol 3, No 3 (2015): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.33.8/ijcto.33.8pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.33.8/346
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.33.8/347
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/727
2017-12-17T14:56:16Z
IJCTO:CASE
Management of Multiple Primary Cancers: What is the Priority?
Dong, Xiang; Westchester Medical Center-
New York Medical College
Barasch, Samuel; Westchester Medical Center-
New York Medical College
Rohan, Darren; Northern Westchester Hospital
Cho, Michael; Westchester Medical Center
Thomas, Leno; Hudson Valley Hematology and Oncology
Koutcher, Lawrence; Department of Radiation Oncology, MidHudson Regional Hospital
Medical Oncology; Surgical Oncolgy; Radiation Oncology
Multiple Primaries, Lynch Syndrome, Colon Cancer, Lung Cancer, Hemangiomablastoma, Gastroesophageal Cancer
Multiple Primary Tumors
Multiple primary cancers are known entity due to the propensity of cancer survivors to develop additional malignancies both from genetic predisposition and exogenous influences. However, the development of triple or quadruple primary cancers, especially presenting simultaneously, presents challenging diagnostic and treatment dilemmas. We report here a patient who presented initially with neurological symptoms. Extensive evaluation and pathologic workup revealed that the patient actually has an intra-medullary vascular neoplasm at the level of upper thoracic spine, mucinous adenocarcinoma of the right lower lobe, poorly differentiated adenocarcinoma of the stomach near the gastro-esophageal (GE) junction, and conventional type adenocarcinoma of the hepatic flexure of the colon. The patient underwent neoadjuvant chemo-radiation for the GE junction carcinoma followed by surgical resection of the three different adenocarcinomas simultaneously as definitive management. This case illustrates the utility of immuno-histochemistry in delineating the site of origin for primary tumors, and the challenges posed when dealing with multiple primary neoplasms concurrently.
International Journal of Cancer Therapy and Oncology
2017-12-24
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto51.19
10.14319/ijcto.51.19
International Journal of Cancer Therapy and Oncology; Vol 5, No 1 (2017): January - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto51.19/ijcto.51.19pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/35
2014-04-12T11:23:46Z
IJCTO:CASE
Atypical presentation of primary renal squamous cell cancer: a case report
Pahwa, Mrinal; Sir Ganga Ram Hospital, New Delhi
Pahwa, Archna Rautela; Lady Hardinge Medical college, New Delhi
Girotra, Mohit; University of Arkansas for Medical Sciences, Little Rock, Arkansas
Chawla, Arun; Southside Kidney Specialist, Richmond, Virginia
Squamous cell cancer; Urothelial malignancy; Phenacetin; Smoking; Squamous metaplasia
Renal squamous cell cancer is one of the rare primary urothelial tumors with only a handful of cases reported in literature. Because of high grade, advanced and late presentation, they herald a grave prognosis. They are frequently associated with calculus disease, smoking, phenacetin consumption and foci of squamous metaplasia due to chronic irritation. Nephroureterectomy is the treatment of choice for such tumors. We hereby present a case of 59 year old female who presented with squamous cell cancer of renal pelvis. The case presented here is different from what has already been reported in literature, as the patient had no antecedent risk factors for renal squamous cell carcinoma.-------------------------------------------------Cite this article as: Pahwa M, Pahwa AR, Girotra M, Chawla A. Atypical presentation of primary renal squamous cell cancer: a case report. Int J Cancer Ther Oncol 2014; 2(1):02015.DOI: http://dx.doi.org/10.14319/ijcto.0201.5
International Journal of Cancer Therapy and Oncology
2014-01-12
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Pahwa
10.14319/ijcto.0201.5
International Journal of Cancer Therapy and Oncology; Vol 2, No 1 (2014): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Pahwa/ijcto.0201.5pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Pahwa/ijcto.0201.5html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Pahwa/45
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/256
2015-03-29T11:59:33Z
IJCTO:CASE
The role of robotic partial cystectomy in a patient with metastatic primary adenocarcinoma of the bladder
James, Katherine; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Vasdev, Nikhil; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Adshead, James M; Department of Urology, Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Lister Hospital, Stevenage
Urologic Oncology
Robotic Partial Cystectomy; Adenocarcinoma Bladder; Metastasis; Outcome
Urological Oncology
Treatment of urachal adenocarcinoma (UA) of the urinary bladder has typically been with radical cystectomy (RC) but more conservative approaches are gaining popularity. Here we present the case of a female patient with metastatic primary bladder UA who was treated with robotic partial cystectomy (RPC) and adjuvant chemotherapy; she is alive with no evidence of disease recurrence or metastatic disease at 5 years. This case provides some of the longest follow-up after RPC to date thereby demonstrating that RPC is a safe and oncologically viable treatment for selected patients even several years after definitive treatment. Patients undergoing RPC benefit from the reduced morbidity associated with this less radical treatment whilst enjoying similarly successful oncological outcomes to RC.
International Journal of Cancer Therapy and Oncology
Nil
2015-02-06
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0301.20
10.14319/ijcto.0301.20
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0301.20/ijcto.0301.20pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/492
2016-07-16T06:19:04Z
IJCTO:CASE
An Extremely Rare and Unusual Case of Retroperitoneal and Pelvic Metastasis from Squamous Cell Carcinoma of Vallecula
Purkayastha, Abhishek; Department of Radiation Oncology
Army Hospital Research and Referral,
DhaulaKuan, Delhi Cantt-110010
Delhi, India
Sharma, Neelam; Department of Radiation Oncology
Army Hospital Research and Referral,
DhaulaKuan, Delhi Cantt-110010
Delhi, India
Suhag, Virender; Department of Radiation Oncology
Army Hospital Research and Referral,
DhaulaKuan, Delhi Cantt-110010
Delhi, India
Radiation Oncology
Metastasis, Pelvic Lymph Nodes, Retroperitoneum, Squamous Cell Carcinoma, Vallecula
Head and neck cancer; metastasis
We report an extremely rare and unusual case of retroperitoneal and pelvic metastasis from primary squamous cell carcinoma of vallecula. Generally carcinoma oropharynx metastasizes to lungs, liver and bone while retroperitoneal and pelvic metastasis is rarely heard of. To the best of our knowledge this case is one of the scantly reported cases ever of this kind in the world. A 60-year-old male presented with dysphagia and hoarseness of voice of four month duration. Computed tomography (CT) scan face and neck showed growth right vallecula. Biopsy of lesion showed squamous cell carcinoma. Metastatic work up was negative. He received definitive chemo-radiation. Patient during follow up presented with dyspepsia, abdominal discomfort and weight loss. Whole body positron emission tomography (WB PET) scan revealed retroperitoneal and pelvic lymph node deposits which were confirmed as metastasis of squamous cell carcinoma by CT guided fine needle aspiration cytology (FNAC). Patient was exhibited palliative chemotherapy but his general condition deteriorated and he finally succumbed to his metastatic illness. This case is being reported to highlight its extreme rarity, the diagnostic and therapeutic challenges it presented and its overall dismal prognosis.
International Journal of Cancer Therapy and Oncology
Nil
2016-06-21
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.10
10.14319/ijcto.42.10
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.10/ijcto.42.10pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.10/495
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.10/496
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/234
2015-03-29T11:59:33Z
IJCTO:CASE
Thoracic spinal cord compression due to xtramedullary haemopoiesis in a patient with beta-thalassemia: complete clinical regression with radiation therapy alone
Saha, Aramita; Department of Radiation Oncology, IPGMER & SSKM Hospital, Kolkata
Chattopadhyay, Subrata; Department of Radiation Oncology, North Bengal Medical College& Hospital, Siliguri
Azam, Mohammad; Department of Radiation Oncology, Medical College, Kolkata
Chatterjee, Koushik; Department of Radiation Oncology, IPGMER & SSKM Hospital, Kolkata
Radiation Oncology
Extramedullary Haemopoiesis; Spinal Cord Compression; Radiation Therapy; Thalassemia
Haematology
Spinal cord compression due to Extramedullary Haemopoesis in beta-thalassemia is extremely rare. Controversies are there between the two modalities of treatment surgery vs radiation therapy. We present here a case of beta thalassemia major in a twenty one years female patient who presented with features of spinal cord compression due to extramedullary haemopoesis.. She was then treated with 3000 cGy of radiation therapy targeted to the T5-T8 region, as 200 cGy/fraction daily, 5 fractions/week , over 6 weeks .The patient’s haemoglobin was elevated from 6.1g/dl to 10.1g/dl, with her haematocrit rising from 26.3 % to 32.8%.Steroid dose was tapered on hospital day number 7.She achieved near full neurological recovery after medical treatment with steroids, blood transfusion and radiation therapy.
International Journal of Cancer Therapy and Oncology
2014-12-08
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0301.7
10.14319/ijcto.0301.7
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0301.7/ijcto.0301.7pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.7/258
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/444
2016-07-16T06:38:36Z
IJCTO:CASE
Imatinib in PDGFR positive malignant solitary fibrous tumour of the pleura
Bigeni, Sarah; Department of Acute Medicine, Mater Dei Hospital, Msida
Jones, Cynthia; Department of Acute Medicine, Mater Dei Hospital, Msida
Galea, Joseph; Department of Cardiothoracic Surgery, Mater Dei Hospital, Msida
Medical Oncology; Pleural malignancy
Malignant Solitary Fibrous Tumours, Imatinib, Pleura, PDGFR
Pleural Oncology
In 2013, two cases of malignant solitary fibrous tumours (MSFTs) were diagnosed in Malta. Both were inoperable at presentation. Both tumours expressed platelet-derived growth factor receptor (PDGFR) with no mutations and the tyrosine kinase inhibitor imatinib was prescribed. Nonetheless, treatment was not as effective as documented in previous case-reports.
International Journal of Cancer Therapy and Oncology
2016-02-15
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.16
10.14319/ijcto.41.16
International Journal of Cancer Therapy and Oncology; Vol 4, No 1 (2016): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.16/ijcto.41.16pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/135
2014-08-16T18:42:04Z
IJCTO:CASE
Primary cerebello-pontine angle melanoma: a case report
Ponni, Arul TR; Department of Radiation Oncology, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Jagannatha, Aniruddha Thekkatte; Department of Neurosurgery, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Gururajachar, Janaki Manur; Department of Radiation Oncology, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Harjani, Ritika; Department of Radiation Oncology, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Koushik, Kirthi AS; Department of Radiation Oncology, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Subramanian, Nirmala; Department of Neurosurgery, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Sowmya, Ramani; Department of Ophthalmology, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Varma, Ravi Gopal; Department of Neurosurgery, M.S. Ramaiah Medical College and Teaching Hospitals, Bangalore India.
Radiation Oncology; Neuro-surgery; Ophthalmology
Primary Central Nervous System Melanoma; Neurosurgery; Radiotherapy; Temozolomide
Radiation Oncology; Neuro-surgery
Intra-cranial melanomas are commonly metastatic from primary melanoma elsewhere in the body. The primary occurrence of a melanoma in the brain parenchyma is rare. We report a case of 38 year aged woman who presented with deviation of left eye and headache. On imaging, a space occupying lesion was found in the left Cerebello-pontine angle and a preoperative diagnosis of meningioma was made. She underwent left retro-mastoid sub-occipital craniectomy and excision of a black vascular tumor. Histopathological examination revealed a melanoma which was confirmed with Immunohistochemical assay. Search for dermal, mucous and ocular lesions were negative. She received adjuvant radiation to the post- operative tumor bed to 5400cGy in 30 fractions using Intensity Modulated Radiation Therapy technique along with concurrent Temozolomide. She tolerated the treatment well and is symptom free 12 months after treatment. Primary Melanomas are rare lesions of the Cerebello-pontine angle and its radiological features, evaluation and management have been discussed.-------------------Cite this article as: Ponni A, Jagannatha A, Gururajachar J, Harjani R, Koushik K, Subramanian N, Sowmya R, Varma R. Primary cerebello-pontine angle melanoma: a case report. Int J Cancer Ther Oncol 2014; 2(3):020315. DOI: 10.14319/ijcto.0203.15
International Journal of Cancer Therapy and Oncology
Dr Yasha TC, Department of Neuropathology, National Institute of Mental Health And Neurosciences (NIMHANS), Bangalore
2014-07-10
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Ponni
10.14319/ijcto.0203.15
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Ponni/ijcto.0203.15pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Ponni/ijcto.0203.15html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Ponni/163
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Ponni/164
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Ponni/165
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Ponni/166
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Ponni/167
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/317
2016-01-03T12:17:09Z
IJCTO:CASE
Extramedullary plasmacytoma of maxilla with cervical nodal metastasis associated with sinonasal aspergillosis
Suhag, Virender; Department of Radiation Oncology, Classified Specialist Pathology, Command Hospital (CC), Lucknow
BS, Sunita; Department of Pathology, Classified Specialist Pathology, Command Hospital (CC), Lucknow
Singh, Ajaya Kumar; Department of Radiodiagnosis, Army Hospital (R&R), Delhi
Dashottar, Sunita; Department of Radiodiagnosis, Military Hospital (CTC), Pune
Medical Oncology, Radiation Oncology
Extra Medullary Plasmacytoma; Maxilla; Aspergillosis
Head and neck
Extramedullary plasmacytoma (EMP) is defined as neoplastic proliferation of plasma cells in the soft tissue. It represents approximately 3% of all plasma cell neoplasms. EMP of the head and neck are very uncommon tumors, representing approximately 0.4% of all head and neck malignancies; amongst them, plasmacytoma of the maxilla is extremely rare. We present a rare case of EMP which had metastasized to multiple cervical lymph nodes and was associated with aspergillosis. The possibility of extramedullary plasmacytoma should be considered when an elderly patient presents with symptoms of recurrent rhinosinusitis not responding to conservative management and imaging shows a destructive soft tissue mass.
International Journal of Cancer Therapy and Oncology
Nil
2015-09-29
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.34.6
10.14319/ijcto.34.6
International Journal of Cancer Therapy and Oncology; Vol 3, No 4 (2015): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.34.6/ijcto.34.6pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/738
2018-06-24T14:49:11Z
IJCTO:CASE
Intraocular breast metastasis: a case report
Garcia, Stephen Joseph; University of the Philippines- Philippine General Hospital
Paraan, Ronald Gonin; University of the Philippines- Philippine General Hospital
Ngelangel, Corazon; University of the Philippines- Philippine General Hospital
Medical Oncology
Intraocular mass, Metastatic breast cancer, Breast cancer
metastatic breast cancer
Breast cancer accounts for approximately 16% of all newly diagnosed cancer cases in the Philippines. Among these, 5% are metastatic at presentation. The eye is an atypical location for metastatic spread from breast cancer. A 53-year-old Filipino female presented with a breast mass with concomitant blurring of vision. Further work-up showed invasive ductal carcinoma with bone metastasis. Ophthalmologic examination showed an intraocular mass with associated exudation and retinal detachment, which explained the blurring of vision. Chemotherapy for the breast cancer subsequently reduced tumor mass of both breast and eye, with progression of both after first line chemotherapy. Clinicians should be wary of patients presenting with a known primary mass lesion with associated ophthalmologic complaints. The possibility of metastatic disease in these patients should warrant ophthalmologic screening to possibly prevent the deterioration of the quality of life of these patients.
International Journal of Cancer Therapy and Oncology
2018-06-24
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.61.5
10.14319/ijcto.61.5
International Journal of Cancer Therapy and Oncology; Vol 6, No 1 (2018): January - December
23304049
en
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/31
2014-04-12T11:23:46Z
IJCTO:CASE
Giant fibroadenoma of the breast in a pre-pubertal girl: a case report
Goyal, Sunder; Professor and Head Minimal Invassive Surgery Department. Kalapna Chawla Medical College, Karnal, Haryana.
Garg, Gulshan; Kalapna Chawla Govt Medical College, Karnal
Narang, Shveta; Kaipna Chawla Govt Medical College, Karnal
Breast, Benign tumour
Juvenile fibroadenoma, Breast conserving surgery, Bilateral giant juvenile fibroadenomas
Begign
Juvenile fibroadenoma comprises about 4% of the total fibroadenomas. The incidence of giant juvenile fibroadenomas is merely 0.5% of all the fibroadenomas. Bilateral giant juvenile fibroadenomas are extremely rare. We are presenting a case of giant juvenile fibroadenomas in an 11-year-old pre-pubertal girl. The diagnosis was made on fine-needle aspiration cytology which was confirmed on histopathology. As these tumors are mostly benign, breast-conserving surgery is done so that patient can lead a normal life without psychological trauma.-----------------------------------Cite this article as: Goyal S, Garg G, Narang S. Giant fibroadenoma of the breast in a pre-pubertal girl: a case report. Int J Cancer Ther Oncol 2014; 2(1):020113.DOI: http://dx.doi.org/10.14319/ijcto.0201.13
International Journal of Cancer Therapy and Oncology
self finance
2014-02-09
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Goyal
10.14319/ijcto.0201.13
International Journal of Cancer Therapy and Oncology; Vol 2, No 1 (2014): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Goyal/ijcto.0201.13pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Goyal/ijcto.0201.13html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/32
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/34
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/35
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/36
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/37
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Goyal/38
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/258
2015-08-15T11:54:27Z
IJCTO:CASE
Volumetric modulated arc therapy for spine SBRT patients to reduce treatment time and intrafractional motion
Amoush, Ahmad; Department of Radiation Oncology, Georgia Regents University, Augusta, Georgia
Dalton, Allison; Department of Radiation Oncology, Georgia Regents University, Augusta, Georgia
Rabatic, Bryan; Department of Radiation Oncology, Georgia Regents University, Augusta, Georgia
Huang, Ke; Department of Radiation Oncology, Georgia Regents University, Augusta, Georgia
Al-Basheer, Ahmad; Department of Radiation Oncology, Georgia Regents University, Augusta, Georgia
Radiation Oncology: Medical physics
VMAT; SBRT; Spine
Case Study
Volumetric modulated arc therapy (VMAT) is an efficient technique to reduce the treatment time and intrafractional motion to treat spine patients presented with severe back pain. Five patients treated with spine stereotactic body radiation therapy (SBRT) using 9 beams intensity modulated radiation therapy (IMRT) were retrospectively selected for this study. The patients were replanned using two arcs VMAT technique. The average mean dose was 104% ± 1.2% and 104.1% ± 1.0% in IMRT and VMAT, respectively (p = 0.9). Accordingly, the average conformal index (CI) was 1.3 ± 0.1 and 1.5 ± 0.3, respectively (p = 0.5). The average dose gradient (DG) distance was 1.5 ± 0.1 cm and 1.4 ± 0.1 cm, respectively (p = 0.3). The average spinal cord maximum dose was 11.6 ± 1.0 Gy and 11.8 ± 1.1 Gy (p = 0.8) and V10Gy was 7.4 ± 1.4 cc and 8.6 ± 1.7 cc (p = 0.4) for IMRT and VMAT, respectively. Accordingly, the average number of monitor units (MUs) was 6771.7 ± 1323.3 MU and 3978 ± 576.7 MU respectively (p = 0.02). The use of VMAT for spine SBRT patients with severe back pain can reduce the treatment time and intrafractional motion.
International Journal of Cancer Therapy and Oncology
2015-02-20
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.6
10.14319/ijcto.0302.6
International Journal of Cancer Therapy and Oncology; Vol 3, No 2 (2015): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.6/ijcto.0302.6pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/508
2016-07-16T06:20:28Z
IJCTO:CASE
Chronic adult T-cell Leukemia in a young male after blood transfusion as a newborn
Colucci, Magali; Department of Haematology, Hospital de Clínicas “José de San Martín”
Cánepa, Camila; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, UBA-CONICET.
Ruggieri, Matías; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, UBA-CONICET.
Berini, Carolina; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, UBA-CONICET.
Halperin, Nora; Department of Haematology
Hospital de Clínicas “José de San Martín”
Rojas, Francisca; Department of Haematology
Hospital de Clínicas “José de San Martín”
Altube, Alejandra; Department of Haematology.
Hospital de Clínicas “José de San Martín”
Cabral Lorenzo, Cecilia; Department of pathology
Hospital de Clínicas “José de San Martín”
Deves, Alberto; Department of Pathology
Hospital de Clínicas “José de San Martín”
Hermine, Olivier; Department of Hematology
INSERM U1163 and CNRS ERL8654, Imagine Institute, Necker Hospital, Assistance publique des hôpitaux de Paris, Paris Descartes University, 75473 Paris Cedex 15
Biglione, Mirna; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA, UBA-CONICET.
Oncology
ATLL, Chronic, HTLV-1, Blood transfusion, Latency
HTLV
Human T-cell Lymphotropic virus type 1 (HTLV-1) is the etiological agent of Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HTM/TSP). Areas of extremely high HTLV-1 prevalence are surrounded by areas of middle or very low prevalence. ATLL is an aggressive lymphoproliferative malignancy of peripheral T cells, with an incidence of less than 5% in HTLV-1-infected individuals. ATLL developed in the majority of cases in individuals who were infected with HTLV-1 by their mothers due to prolonged breastfeeding. In non-endemic areas, ATLL is usually limited to immigrants, their sexual partners and descendants from endemic regions. Very few cases of ATLL have been diagnosed in recipient patients few years after an organ transplantation or blood transfusion worldwide. Achieving an accurate and fast diagnosis of ATLL can be challenging due to the lack of professional experience, delayed consultation and difficulty in its sub-classification. We present a case of a delayed onset of a chronic ATLL in an 18-years-old male who was transfused with blood components as a premature newborn in Buenos Aires, a non-endemic city of South America.
International Journal of Cancer Therapy and Oncology
CONICET
2016-06-23
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.8
10.14319/ijcto.42.8
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.8/ijcto.42.8pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/194
2015-03-29T11:59:33Z
IJCTO:CASE
A case of endometrial carcinoma with age related hyperkyphosis treated with definitive radiotherapy
Murthy, Arvind S; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Manur, Janaki G; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Ponni, Arul TR; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Koushik, Kirthi AS; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Alva, Ram C; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Somashekar, Mohan K; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Kannan, Ram A; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Harjani, Ritika R; Department of Radiation Oncology, M S Ramaiah Medical College, Bangalore
Radiation Oncology;Brachytherapy
Brachytherapy; Endometrial Cancer; Hyperkyphosis
Gynecologic Oncology
This report describes a simple brachytherapy procedure in a patient with endometrial cancer with age related hyperkyphosis. Sixty-eight year-old postmenopausal woman with age related hyperkyphosis presented with endometrial carcinoma, and the patient was not operated on due to associated pelvic deformity. The patient received whole pelvic radiation followed by uterovaginal brachytherapy. Patient was supported with soft pillows to support her exaggerated anterior concavity during brachytherapy procedure and execution. The brachytherapy dose was 6 Gy per fraction per week for 3 weeks using image guidance. This is probably the first reported case of endometrial cancer with age related hyperkyphosis. In spite of the associated skeletal problems, a simple brachytherapy procedure is possible and provides good result.
International Journal of Cancer Therapy and Oncology
2014-12-14
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0301.6
10.14319/ijcto.0301.6
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0301.6/ijcto.0301.6pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.6/222
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/512
2016-07-16T06:13:38Z
IJCTO:CASE
Application of therapeutic drug monitoring of imatinib for individual treatment of gastrointestinal stromal tumor
Fukuda, Koji; Department of Clinical Oncology, Graduate School of Medicine, Akita
Shimazu, Kazuhiro; Department of Clinical Oncology, Graduate School of Medicine, Akita
Yoshida, Taichi; Department of Clinical Oncology, Graduate School of Medicine, Akita
Inoue, Masahiro; Department of Clinical Oncology, Graduate School of Medicine, Akita
Miura, Masatomo; Department of Pharmacy, University Hospital, Akita University, 010-8543 Hondo 1-1-1, Akita
Shibata, Hiroyuki; Department of Clinical Oncology, Graduate School of Medicine, Akita
Medical Oncology
Therapeutic drug monitoring, Imatinib, Gastrointestinal stromal tumor
Many molecular target agents are continuously administered at fixed dosages. Imatinib, which can control the growth of a gastrointestinal stromal tumor, is administrated at 400 mg/day. However, many patients cannot continue treatment because of adverse events, such as neutropenia. To obtain the best therapeutic response while maintaining quality of life, individualization should be considered. Study participants were gastrointestinal stromal tumor patients who required treatment with imatinib. Therapeutic drug monitoring was conducted using high-performance liquid chromatography. In our study, the trough (lowest) concentration that a drug reaches before the next dose is administered differed among patients. The grades of adverse events also differed individually. Moreover, the dosage that was necessary to shrink gastrointestinal stromal tumor differed in cases by cases. Dosage was modified according to the balance between blood concentration and therapeutic responses in order to minimize adverse events for individual patients, and to maximize the effect as the responses differed among patients. It was shown that based on therapeutic drug monitoring, individualization enabled the patients who may not normally continue the typical treatment to tolerate imatinib. According to the therapeutic drug monitoring, individualization of dosage of imatinib could improve the patients’ outcomes in both ends, therapeutic and adeverse responses.
International Journal of Cancer Therapy and Oncology
2016-05-31
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.11
10.14319/ijcto.42.11
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.11/ijcto.42.11pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.11/587
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/83
2014-08-16T18:42:04Z
IJCTO:CASE
A case report on nasolabial cyst
Goyal, Sunder; Department of Surgery, Kalpana Chawla Govt Medical College, Karnal, Haryana, India.
Sharma, Jayvardhan; Department of Ear Nose Throat (ENT), Kalpana Chawla Govt Medical College, Karnal, Haryana, India.
Sharma, Nidhi; Department of Paediatrics, Kalpana Chawla Govt Medical College, Karnal, Haryana, India.
Swelling
Nasolabial Cyst; Embryonic; Nasolabial Fold
Facial region
The nasolabial cyst (NLC) is an uncommon clinical entity and is generally unilateral. It is benign in nature and is embryonic in origin and only one case with malignancy has been reported. It is located in the nasolabial folds. Most of time it is an asymptomatic deformity of face and rarely can result in nasal obstruction if it is bilateral. Its diagnosis is clinical and treatment is surgical excision. A 16 years brown female patient presented with bulging in left nasolabial region. She was treated with surgery...........................................................Cite this article as:Goyal S, Sharma J, Sharma N. A case report on nasolabial cyst. Int J Cancer Ther Oncol 2014; 2(3):020311. DOI: 10.14319/ijcto.0203.11
International Journal of Cancer Therapy and Oncology
2014-07-14
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/0203.11
10.14319/ijcto.0203.11
International Journal of Cancer Therapy and Oncology; Vol 2, No 3 (2014): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0203.11/0203.11pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0203.11/ijcto.0203.11html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0203.11/114
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0203.11/115
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0203.11/124
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0203.11/125
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/321
2016-01-03T12:17:09Z
IJCTO:CASE
Pancreatic neuroendocrine tumor in an individual with Von Hippel Lindau syndrome. A case report and review literature
Ganguly, Sandip; Department of Medical Oncology, Kidwai Memorial Institute of Oncology (KMIO), Bangalore
Jacob, Linu A; Department of Medical Oncology, Kidwai Memorial Institute of Oncology (KMIO), Bangalore
Biswas, Siddhartha; Department of Pathology, Kidwai Memorial Institute of Oncology (KMIO), Bangalore
Lakshmaiah, K C; Department of Medical Oncology, Kidwai Memorial Institute of Oncology (KMIO), Bangalore
Medical Oncology
Pancreatic Neuro Endocrine; Von-Hippel Lindau; Sunitinib
Neuroendocrine tumors
Von Hippel Lindau (VHL) disease is a heritable cancer syndrome characterized by VHL gene mutation in 3p chromosome. Mutations occur at the exons. Rarely mutations at introns have been reported. It leads to accumulation of Hypoxic ischemic factor α (HIF α) which in turn leads to uncontrolled cellular proliferation. Few reports of pancreatic neuroendocrine tumors (PNETs) are there in the literature. Most of them are associated with a mutation in the exon of VHL gene. Association with intron mutation is not there. Here we are reporting a case of PNET in a patient who has a simultaneous mutation both at the exon and the intron.
International Journal of Cancer Therapy and Oncology
2015-11-22
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.34.10
10.14319/ijcto.34.10
International Journal of Cancer Therapy and Oncology; Vol 3, No 4 (2015): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.34.10/ijcto.34.10pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.34.10/333
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/49
2014-05-14T17:01:18Z
IJCTO:CASE
Multiple adenomatoid tumours in the Epididymis and Tunica vaginalis: Case report
Abroaf, Ahmed; Urology Department, Freeman Hospital
Newcastle Upon Tyne
Veeratterapillay, Rajan; Urology Department, Freeman Hospital
Newcastle Upon Tyne
Vasdev, Nikhil; Urology Department, Freeman Hospital
Newcastle Upon Tyne
Majo, Joaquim; Department of Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne
El-Sherif, Amira; Department of Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne
Paez, Edgar; Urology Department, Freeman Hospital
Newcastle Upon Tyne
Medical Oncology
Tumour; Adenomatoid: Tunica; Epididymis
We describe the case of a 65 year-old male presenting with a tender right testicular mass, confirmed to be a tumour on ultrasound. The patient underwent a radical inguinal orchidectomy and histology revealed multiple adenomatoid tumours in epididymis and tunica vaginalis. This is an infrequent benign tumour of mesothelial origin that has rarely been reported as multiple lesions in the literature. Immunohistochemistry demonstrates that adenomatoid tumour and mesotheliomas share the expression of podoplanin (D2-40) which is helpful to differentiate them from carcinomas. On the other hand adenomatoid tumour is differentiated from mesothelioma on morphological grounds since the former does not exhibit cellular atypia, mitotic activity or bland focal tumour necrosis. Although testis preserving surgery can be an option for benign adenomatoid tumours, most patients (as in our case) proceed to orchidectomy as diagnosing them confidently can be difficult.---------------------------Cite this article as: Abroaf A, Veeratterapillay R, Vasdev N, Majo J, Sherif AE, Paez E. Multiple adenomatoid tumours in the Epididymis and Tunica vaginalis : Case Report. Int J Cancer Ther Oncol 2014; 2(1):02021.DOI: http://dx.doi.org/10.14319/ijcto.0202.1
International Journal of Cancer Therapy and Oncology
2014-03-25
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/Abroaf
10.14319/ijcto.0202.1
International Journal of Cancer Therapy and Oncology; Vol 2, No 2 (2014): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/Abroaf/ijcto.0202.1pdf
http://www.ijcto.org/index.php/IJCTO/article/view/Abroaf/ijcto.0202.1html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/Abroaf/48
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/291
2015-08-15T11:54:27Z
IJCTO:CASE
Xanthogranulomatous Colitis masquerading as carcinoma of colon
Kapoor, Akhil; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, Rajasthan
Soni, Dharam Pal; Department of Pathology, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, Rajasthan
Paramanandhan, Murali; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, Rajasthan
Kini, Lata; Department of Pathology, Core Diagnostics Pvt. Limited, New Delhi
Beniwal, Surender; Department of Medical Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, Rajasthan
Kumar, Harvindra; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, Rajasthan
Oncology; Oncopathology; Surical Oncology
Xanthogranulomatous Inflammation; Colitis; Immunohistochemistry; Colon Cancer
Xanthogranulomatous inflammation (XGI) is an uncommon pathological diagnosis involving various organ systems, the most common being the gall bladder and kidney. It can masquerade as a malignant mass thus, requiring a clinical suspicion for accurate and timely diagnosis. A 65-year-old woman presented with acute onset of obstipation and vomiting suggesting acute obstruction. Contrast enhanced computed tomography of abdomen revealed a solid irregular mass in the ascending colon with large necrotic areas and surrounding enlarged nodes suggestive of malignancy arising from right colon. Right hemi-colectomy was performed. Histopathology of the surgical specimen showed florid inflammatory infiltrate with collection of histiocytes, lymphocytes and polymorphs. Further immunohistochemistry was conducted, and CD68 and CD45 were found to be positive and pan-cytokeratin was negative. A clinico-pathological diagnosis was thus established to be xanthogranulomatous colitis.
International Journal of Cancer Therapy and Oncology
2015-02-20
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.5
10.14319/ijcto.0302.5
International Journal of Cancer Therapy and Oncology; Vol 3, No 2 (2015): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.0302.5/ijcto.0302.5pdf
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/507
2016-09-18T08:59:14Z
IJCTO:CASE
Extra-abdominal desmoid tumor: A case report
Kopric, Dijana; Department of Medical Oncology, University Clinical Center Tuzla, Tuzla
Alidzanovic Nurkanovic, Lejla; Department of Medical Oncology, University Clinical Center Tuzla, Tuzla
Alidzanovic, Jasmina; Department of Medical Oncology, University Clinical Center Tuzla, Tuzla
Altumbabic, Amela; Department of Medical Oncology, University Clinical Center Tuzla, Tuzla
Arnautalic, Lejla; Department of Radiology, University Clinical Center Tuzla, Tuzla
Iljazovic, Ermina; Department of Pathology, University Clinical Center Tuzla, Tuzla
Medical Oncology; Radiation Oncology
Aggressive fibromatosis, Extra-abdominal, Desmoid tumor, Irradiation, Imatinib
Desmoid tumor represents a rare monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Although histologically benign, desmoids are locally invasive and associated with a high local recurrence rate, but lack of metastatic potential. Many issues regarding the optimal treatment of patients with desmoids remain controversial. Surgical resection and radiotherapy are standard treatment options for these patients. Due to heterogeneity of the biological behavior of desmoids, including long periods of stable disease or even spontaneous regression, treatment needs to be individualized to optimize local tumor control and preserve patient's quality of life. Therapeutic approaches to the treatment of recurrent or unresectable desmoid tumors comprise anti-hormonal therapy, non-steroidal anti-inflammatory drugs, classic chemotherapy regimens and tyrosine kinase inhibitor, with highly variable results. It has not yet been possible to establish an optimal therapy protocol for this disease. In this case report we present our experience with the treatment of recurrent extra-abdominal desmoid tumor.
International Journal of Cancer Therapy and Oncology
2016-07-16
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.43.3
10.14319/ijcto.43.3
International Journal of Cancer Therapy and Oncology; Vol 4, No 3 (2016): July - September
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.43.3/ijcto.43.3pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.3/515
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.3/516
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.3/517
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.3/518
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.43.3/544
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/230
2015-03-29T11:59:33Z
IJCTO:CASE
Bilateral pulmonary nodules after the successful treatment of a mediastinal seminoma
Reche, Encarnacion Santos; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Bruixola, Gema; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Salvador, Carmen; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Mancheño, Nuria; Department of Pathology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Niño, Oscar; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Escoin, Corina; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
Aparicio, Jorge; Department of Medical Oncology, Hospital Universitario y Politecnico La Fe, Valencia, Spain
MEDICAL ONCOLOGY;RADIATION ONCOLOGY; INTERNAL MEDICINE
Seminoma; Langerhans Cell Histiocytosis; Lung Nodules
Germ cell tumors are unusual, but they represent the most common neoplasm in young men. Since the introduction of cisplatin-based chemotherapy, most cases are expected to be cured today. Intensive monitoring of these patients during follow-up is required to rule out relapses or late complications of therapy. We present the case of a 21-year-old male who developed extensive lung dissemination by Langerhans cell histiocytosis eight months after the successful treatment of a bulky mediastinal seminoma.
International Journal of Cancer Therapy and Oncology
2014-12-30
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0301.11
10.14319/ijcto.0301.11
International Journal of Cancer Therapy and Oncology; Vol 3, No 1 (2015): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0301.11/ijcto.0301.11pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0301.11/255
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/477
2016-07-16T06:14:35Z
IJCTO:CASE
Borderline phyllodes tumor of breast in a premenarchal girl: A relatively common tumor at an uncommon age
Kapoor, Akhil; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College, Bikaner, Rajasthan
Charan, Ishwar; Department of Surgery, Sardar Patel Medical College, Bikaner, Rajasthan
Singhal, Mukesh Kumar; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College, Bikaner, Rajasthan
Kumar, Harvindra Singh; Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College, Bikaner, Rajasthan
Oncology; Borderline tumors
Phyllodes tumor, breast, prepubertal girl
Phyllodes tumors are relatively rare breast lesions that usually occur in the age group of 35 ‒ 55 years. It is a very rare diagnosis in young girls, particularly at prepubertal age. Because of the uncommon nature of this tumor in children, it may be misdiagnosed leading to inappropriate management. We report a case of a 9–year-old girl who was diagnosed as a case of borderline phyllodes tumor left breast. Simple mastectomy without axillary staging was performed. She has recovered well and is on follow up.
International Journal of Cancer Therapy and Oncology
Nil
2016-06-05
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.13
10.14319/ijcto.42.13
International Journal of Cancer Therapy and Oncology; Vol 4, No 2 (2016): April - June
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.42.13/ijcto.42.13pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/482
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/483
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/484
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/485
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/486
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.42.13/590
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/150
2014-12-13T14:36:25Z
IJCTO:CASE
Solitary bone metastasis to the tibia from colorectal cancer- A case report
Alnajjar, Abdulsalam; Department of Medical oncology, Kuwait Cancer Control Centre, Safat, Kuwait.
Mohanty, Asit Kumar; Department of Medical oncology, Kuwait Cancer Control Centre, Safat, Kuwait.
Medical Oncology
Solitary Bone Metastasis; Tibia; Colorectal Cancer; Chemotherapy; Radiotherapy
The onset of osseous metastases during the course of colorectal cancer is not common. Although rare, they usually appear in the axial skeleton. In our report, we refer to the case of a 48-year-old patient who presented with colon cancer and eventually developed a solitary bone metastasis in the upper end of left tibia. At the time of diagnosis and staging investigations, the patient had only a primary disease.------------------------------------------------Cite this article as:Alnajjar A, Mohanty AK. Solitary bone metastasis to the tibia from colorectal cancer- A case report. Int J Cancer Ther Oncol 2014; 2(4):02045. DOI: 10.14319/ijcto.0204.5
International Journal of Cancer Therapy and Oncology
2014-09-08
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/html
http://www.ijcto.org/index.php/IJCTO/article/view/0204.5
10.14319/ijcto.0204.5
International Journal of Cancer Therapy and Oncology; Vol 2, No 4 (2014): October - December
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/0204.5/ijcto.0204.5pdf
http://www.ijcto.org/index.php/IJCTO/article/view/0204.5/ijcto.0204.5html
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.5/175
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.5/176
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/0204.5/183
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
oai:ojs.ijcto.org:article/381
2016-07-16T06:36:34Z
IJCTO:CASE
Long term palliation of a metastatic primary gliosarcoma with stereotactic body radiotherapy
Manur Gururajachar, Janaki; Department of Radiation Oncology, M. S. Ramaiah Medical College Bangalore, Karnataka
Polisetty, Sweta; Department of Radiation Oncology, M. S. Ramaiah Medical College Bangalore, Karnataka
Radiation Oncology
Gliosarcoma, Lung Metastases, SBRT
Palliation
Primary gliosarcoma (PGS) is rare and is known for extra cranial metastases. The overall outcome is dismal and hence the focus is on providing the best quality of life. This report describes a seventy-year-old lady who at presentation had metastatic primary gliosarcoma with intractable cough. Her lung lesion was treated with stereotactic body radiotherapy (SBRT) to a dose of 10 Gy per fraction for three consecutive days. She was free of cough till her death at eighteen months after treatment. This is probably the first reported case of excellent long-term quality of life in a patient of metastatic primary gliosarcoma.
International Journal of Cancer Therapy and Oncology
2015-12-23
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.4
10.14319/ijcto.41.4
International Journal of Cancer Therapy and Oncology; Vol 4, No 1 (2016): January - March
23304049
eng
http://www.ijcto.org/index.php/IJCTO/article/view/ijcto.41.4/ijcto.41.4pdf
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/398
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/399
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/441
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/446
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/447
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/448
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/449
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/450
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/451
http://www.ijcto.org/index.php/IJCTO/article/downloadSuppFile/ijcto.41.4/452
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).